Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Total revenues, net	$ 464,370	$ 250,314	$ 83,803
Operating expenses:
Cost of product sales	33,745	20,443	8,035
Selling, general and administrative	409,864	358,782	272,611
Research and development	180,142	134,715	88,845
Total operating expenses	623,751	513,940	369,491
Loss from operations	(159,381)	(263,626)	(285,688)
Interest income	20,343	7,376	1,568
Loss before provision for income taxes	(139,038)	(256,250)	(284,120)
Income tax expense	(636)	(6)	(6)
Net loss	$ (139,674)	$ (256,256)	$ (284,126)
Net loss per common share:
Basic (in dollars per share)	$ (1.46)	$ (2.72)	$ (3.50)
Diluted (in dollars per share)	$ (1.46)	$ (2.72)	$ (3.50)
Weighted average number of common shares:
Basic (in shares)	95,881,729	94,046,670	81,253,394
Diluted (in shares)	95,881,729	94,046,670	81,253,394
Product sales, net
Total revenues, net	$ 462,175	$ 249,132	$ 81,708
Grant revenue
Total revenues, net	$ 2,195	$ 1,182	$ 2,095